Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

On the surface, the formula for weight loss seems simple: eat less and move more. But giving that advice to someone with ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

The following is a summary of “Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...

Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...

These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...

Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...